HIV Medications for HIV Prevention: News & Research
- 96% Campaign Asks Obama to "Pay Attention to Science" and Scale Up Global Access to ARVs (October 10, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- 96% Campaign Asks Obama to "Pay Attention to Science" and Scale Up Global Access to ARVs (October 10, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Sign On: Treatment Prevents Transmission -- Obama, Stand Up for Treatment Expansion Worldwide (October 7, 2011)
From HIV Prevention Justice Alliance
- What Makes the HPTN 052 Study So Significant? (September/October 2011)
An interview with Myron Cohen, the study's lead author.
In Positively Aware, from Test Positive Aware Network
- Conference Update From IAS 2011: Prevention (September/October 2011)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
 Editor's Note: Back to the Drawing Board (September/October 2011)
"As programs continue to get slashed, doors closed, and positions eliminated, disaster awaits us all if we don't start now to insist on increased funding for treatment education," Jeff Berry writes.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Microbicide Trials Network Stops Tenofovir Arm of Study After Findings Show Drug Less Effective Than Anticipated (September 29, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
 NIH Modifies "VOICE" HIV Prevention Study in Women (September 28, 2011)
Oral tenofovir discontinued in clinical trial.
From U.S. National Institute of Allergy and Infectious Diseases
- California: San Francisco Set to Offer Anti-HIV Pill to Gay Men (September 13, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
 San Fran Very Close to Becoming First City to Pass Out PrEP (September 8, 2011)
From TheBody.com
- Preparing for PrEP (September 7, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- ARVs as Prevention: Great Promise and the Questions That Remain (September 2011)
To read PDF, click here.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Preventive Technologies, Immune-Based and Gene Therapies and Research Toward a Cure (September 2011)
In 2011 Pipeline Report, from Treatment Action Group and HIV i-Base
- The iPrEx Results: Lifting Hopes, Raising Questions (Summer/Fall 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Tenofovir/Emtricitabine PreP Shows Protective Effect (Summer/Fall 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- HPTN 052 Study Stopped Early: Significant Reduction in HIV Transmission From Early Use of HIV Treatment in Serodifferent Partners (August 31, 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Groups Press Government for Swift Action on New Prevention Tool (August 30, 2011)
From Black AIDS Institute
- Tenofovir/FTC vs. Tenofovir as Daily Oral PrEP: Preliminary Results From Partners PrEP (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Treatment Is Prevention: ARV Treatment in HPTN-052 Reduces Transmission by at Least 96%: Single Transmission in Treatment Arm Occurred Prior to Viral Suppression (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Forum for Collaborative HIV Research Discusses PrEP (August 25, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
 Treatment Is Prevention Part 1: A Blog Entry by Gary Bell (August 18, 2011)
"As we, as a society, struggle with finding new and creative ways to reduce the transmission of HIV, it was only natural to consider the impact a medical model might have on this challenge. Perhaps one of the most exciting studies within the last several months demonstrates the benefit of immediate, aggressive HIV treatment in reducing transmission."
From TheBody.com
|
Advertisement
|
Email
Glossary
